A Single Dose, Open-label, One Sequence, 2-period, Crossover Study to Characterize the Pharmacokinetics and Pharmacodynamics of Ticagrelor and Prasugrel in Healthy Male Adult Subjects

Trial Profile

A Single Dose, Open-label, One Sequence, 2-period, Crossover Study to Characterize the Pharmacokinetics and Pharmacodynamics of Ticagrelor and Prasugrel in Healthy Male Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Feb 2015

At a glance

  • Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
  • Indications Acute coronary syndromes; Coronary artery disease; Embolism and thrombosis; Peripheral arterial disorders; Sickle cell anaemia; Stroke
  • Focus Pharmacodynamics
  • Most Recent Events

    • 11 Jul 2013 Planned End Date 1 Aug 2013 added as reported by ClinicalTrials.gov.
    • 11 Jul 2013 Planned initiation date 1 Jul 2013 added as reported by ClinicalTrials.gov.
    • 03 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top